Figure 2From: Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivativeInhibition by progestogens of estrogen-stimulated uterine estrogen receptor content in OVX rats. ANOVA, analysis of variance; OVX, ovariectomized; E2, 17β-estradiol; NOMAC, nomegestrol acetate; MPA, medroxyprogesterone acetate; SD, standard deviation. * P<0.05; ** P<0.01 compared with E2-only treated rats (ANOVA).Back to article page